Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes

✍ Scribed by Heise, T.; Seewaldt-Becker, E.; Macha, S.; Hantel, S.; Pinnetti, S.; Seman, L.; Woerle, H. J.

• Book ID: 120293235
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 790 KB
• Volume: 15
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/dom.12073